Does Rallies show 13F holders for CAH?

Yes. Rallies tracks hedge fund and 13F ownership data for CAH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CAH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CAH. It does not provide personalized investment advice.

CAH (Cardinal Health, Inc.) Stock Analysis - Hedge Fund Holdings

Cardinal Health, Inc. (CAH) is a publicly traded Healthcare sector company. As of May 21, 2026, CAH trades at $199.40 with a market cap of $46.79B and a P/E ratio of 0.00. CAH moved -0.48% today. Year to date, CAH is -3.03%; over the trailing twelve months it is +28.73%. Its 52-week range spans $106.98 to $233.60. Analyst consensus is strong buy with an average price target of $246.00. Rallies surfaces CAH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CAH stock?

Hedge funds tracked by Rallies that own CAH include Elliott Investment, Farallon Capital, Panagora Asset, Glenview Capital, and Bridgewater Associates. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cardinal Health, Inc..

CAH Key Metrics

Key financial metrics for CAH
Metric	Value
Price	$199.40
Market Cap	$46.79B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.52%
52-Week High	$233.60
52-Week Low	$106.98
Volume	1.49M
Avg Volume	0
Revenue (TTM)	$244.67B
Net Income	$1.68B
Gross Margin	3.69%

Top Hedge Funds Holding CAH

Elliott Investment holds 2.00M shares of CAH, changed +0.00% as of Sep 30, 2024.
Farallon Capital holds 368.00K shares of CAH, changed -36.11% as of Mar 31, 2026.
Panagora Asset holds 208.15K shares of CAH, changed -13.93% as of Mar 31, 2026.
Glenview Capital holds 203.25K shares of CAH, changed +0.00% as of Dec 31, 2023.
Bridgewater Associates holds 115.23K shares of CAH, changed -46.82% as of Mar 31, 2026.

Latest CAH News

Cardinal Health drops as investors fade Q3 outlook hike, refocus on recall risk — May 6, 2026
Cardinal Health slides despite Q3 EPS beat as traders focus on GAAP and cash flow — Apr 30, 2026
Cardinal Health reports 11% revenue gain, narrows FY26 EPS outlook to $10.70-$10.80 — Apr 30, 2026
Cardinal Health Expands Higher-Growth Services After Health Care Lags 7% — Apr 28, 2026
Cardinal Health slides 3% on profit-taking and pre-earnings repositioning — Apr 22, 2026

Recent CAH Insider Trades

Greene Michelle D. sold 100 (~$22.86K) on Feb 27, 2026.
Greene Michelle D. sold 2.65K (~$604.53K) on Feb 27, 2026.
Alt Aaron E sold 2.33K (~$524.96K) on Feb 18, 2026.

CAH Analyst Consensus

12 analysts cover CAH: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $246.00.

Common questions about CAH

Who owns CAH stock?: Hedge funds tracked by Rallies that own CAH include Elliott Investment, Farallon Capital, Panagora Asset, Glenview Capital, and Bridgewater Associates. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cardinal Health, Inc..
Does Rallies show 13F holders for CAH?: Yes. Rallies tracks hedge fund and 13F ownership data for CAH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CAH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CAH. It does not provide personalized investment advice.